BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14973093)

  • 1. Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
    Frank DH; Roe DJ; Chow HH; Guillen JM; Choquette K; Gracie D; Francis J; Fish A; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):299-303. PubMed ID: 14973093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.
    Thompson P; Roe DJ; Fales L; Buckmeier J; Wang F; Hamilton SR; Bhattacharyya A; Green S; Hsu CH; Chow HH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Martinez ME; Jacobs E; Ashbeck EL; Alberts DS; Lance P
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1381-93. PubMed ID: 23060037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
    Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
    Scheiman JM; Cryer B; Kimmey MB; Rothstein RI; Riff DS; Wolfe MM
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):290-5. PubMed ID: 15067622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A report of high-dose selenium supplementation: response and toxicities.
    Reid ME; Stratton MS; Lillico AJ; Fakih M; Natarajan R; Clark LC; Marshall JR
    J Trace Elem Med Biol; 2004; 18(1):69-74. PubMed ID: 15487766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P; Koncz T; Pan S; Lowry S
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib.
    Brenner SS; Herrlinger C; Dilger K; Mürdter TE; Hofmann U; Marx C; Klotz U
    Clin Pharmacokinet; 2003; 42(3):283-92. PubMed ID: 12603175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
    Reckamp KL; Krysan K; Morrow JD; Milne GL; Newman RA; Tucker C; Elashoff RM; Dubinett SM; Figlin RA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3381-8. PubMed ID: 16740761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
    Moberly JB; Xu J; Desjardins PJ; Daniels SE; Bandy DP; Lawson JE; Link AJ; Truitt KE
    Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.
    Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D
    Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
    Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
    Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.
    Gimbel JS; Brugger A; Zhao W; Verburg KM; Geis GS
    Clin Ther; 2001 Feb; 23(2):228-41. PubMed ID: 11293556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
    Kim JY; Alam F; Chung SW; Park J; Jeon OC; Kim SY; Son WC; Byun Y
    Anticancer Drugs; 2014 Oct; 25(9):1061-71. PubMed ID: 25003253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies.
    Larsen EH; Hansen M; Paulin H; Moesgaard S; Reid M; Rayman M
    J AOAC Int; 2004; 87(1):225-32. PubMed ID: 15084104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.